Matches in SemOpenAlex for { <https://semopenalex.org/work/W2789776784> ?p ?o ?g. }
- W2789776784 endingPage "iv107" @default.
- W2789776784 startingPage "iv99" @default.
- W2789776784 abstract "There is a big need for the development of novel therapies for the safe management of chronic pain associated with OA. Here we reviewed PubMed (2015 onward) and ClinicalTrials.gov for ongoing and recently completed trials where pain in OA is the primary outcome measure. Three broad categories were identified: biological therapies, small molecules and cryoneurolysis. The most promising new strategy is blockade of nerve growth factor with antibodies. Two anti-nerve growth factor antibodies, tanuzemab and fasinumab, are in active development after the 2010 hold on trials was lifted in 2015. In addition, several active clinical trials are testing distinct mechanism-based interventions, including cytokine inhibition, selective μ, δ or κ opioid receptor agonists, zoledronate and intra-articular capsaicin. In addition to pharmacological approaches, cryoneurolytic strategies that directly target peripheral nerves may play a role in OA pain management, but efficacy profiles and long-term effects of such treatments need more study. Clearly, the therapeutic landscape for OA pain is rapidly expanding. Since symptomatic OA is a heterogeneous disease, the challenge will be to identify patients that will benefit the most from specific approaches." @default.
- W2789776784 created "2018-03-29" @default.
- W2789776784 creator A5045203576 @default.
- W2789776784 creator A5080531336 @default.
- W2789776784 creator A5089546365 @default.
- W2789776784 date "2018-01-17" @default.
- W2789776784 modified "2023-10-15" @default.
- W2789776784 title "What is new in pain modification in osteoarthritis?" @default.
- W2789776784 cites W1548981124 @default.
- W2789776784 cites W1599615937 @default.
- W2789776784 cites W172810081 @default.
- W2789776784 cites W178176148 @default.
- W2789776784 cites W1836548413 @default.
- W2789776784 cites W1875380750 @default.
- W2789776784 cites W1966648978 @default.
- W2789776784 cites W1975849817 @default.
- W2789776784 cites W1995915070 @default.
- W2789776784 cites W1995954071 @default.
- W2789776784 cites W2015463772 @default.
- W2789776784 cites W2022338924 @default.
- W2789776784 cites W2026277675 @default.
- W2789776784 cites W2034394772 @default.
- W2789776784 cites W2035694773 @default.
- W2789776784 cites W2036491373 @default.
- W2789776784 cites W2038091223 @default.
- W2789776784 cites W2049440043 @default.
- W2789776784 cites W2051476546 @default.
- W2789776784 cites W2055167420 @default.
- W2789776784 cites W2064741697 @default.
- W2789776784 cites W2076104046 @default.
- W2789776784 cites W2081338578 @default.
- W2789776784 cites W2083591225 @default.
- W2789776784 cites W2084610846 @default.
- W2789776784 cites W2097699861 @default.
- W2789776784 cites W2098082628 @default.
- W2789776784 cites W2105539667 @default.
- W2789776784 cites W2113670619 @default.
- W2789776784 cites W2122341009 @default.
- W2789776784 cites W2129650714 @default.
- W2789776784 cites W2133915381 @default.
- W2789776784 cites W2134905207 @default.
- W2789776784 cites W2135724744 @default.
- W2789776784 cites W2137787323 @default.
- W2789776784 cites W2230939216 @default.
- W2789776784 cites W2297765836 @default.
- W2789776784 cites W2313270205 @default.
- W2789776784 cites W2328721585 @default.
- W2789776784 cites W2330491371 @default.
- W2789776784 cites W2404637903 @default.
- W2789776784 cites W2412430823 @default.
- W2789776784 cites W2432828442 @default.
- W2789776784 cites W2481203471 @default.
- W2789776784 cites W2524788083 @default.
- W2789776784 cites W2531574227 @default.
- W2789776784 cites W2547618635 @default.
- W2789776784 cites W2562870279 @default.
- W2789776784 cites W2566211026 @default.
- W2789776784 cites W2566654989 @default.
- W2789776784 cites W2580313211 @default.
- W2789776784 cites W2594986299 @default.
- W2789776784 cites W2603827876 @default.
- W2789776784 cites W2604984760 @default.
- W2789776784 cites W2605481683 @default.
- W2789776784 cites W2606038676 @default.
- W2789776784 cites W2609354761 @default.
- W2789776784 cites W2610483407 @default.
- W2789776784 cites W2616445893 @default.
- W2789776784 cites W2617180317 @default.
- W2789776784 cites W2621162870 @default.
- W2789776784 cites W2722711213 @default.
- W2789776784 cites W2735521919 @default.
- W2789776784 cites W2981591518 @default.
- W2789776784 cites W4237877170 @default.
- W2789776784 cites W4296896314 @default.
- W2789776784 doi "https://doi.org/10.1093/rheumatology/kex522" @default.
- W2789776784 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5905627" @default.
- W2789776784 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29361112" @default.
- W2789776784 hasPublicationYear "2018" @default.
- W2789776784 type Work @default.
- W2789776784 sameAs 2789776784 @default.
- W2789776784 citedByCount "46" @default.
- W2789776784 countsByYear W27897767842018 @default.
- W2789776784 countsByYear W27897767842019 @default.
- W2789776784 countsByYear W27897767842020 @default.
- W2789776784 countsByYear W27897767842021 @default.
- W2789776784 countsByYear W27897767842022 @default.
- W2789776784 countsByYear W27897767842023 @default.
- W2789776784 crossrefType "journal-article" @default.
- W2789776784 hasAuthorship W2789776784A5045203576 @default.
- W2789776784 hasAuthorship W2789776784A5080531336 @default.
- W2789776784 hasAuthorship W2789776784A5089546365 @default.
- W2789776784 hasBestOaLocation W27897767841 @default.
- W2789776784 hasConcept C126322002 @default.
- W2789776784 hasConcept C142724271 @default.
- W2789776784 hasConcept C177713679 @default.
- W2789776784 hasConcept C1862650 @default.
- W2789776784 hasConcept C204787440 @default.
- W2789776784 hasConcept C2776164576 @default.